Tag: Chemotherapy
Pediatric maxillary mesenchymal chondrosarcoma with HEY1::NCOA2 fusion
—
in PathologyCase report of mesenchymal chondrosarcoma in a 13-year-old with HEY1::NCOA2 fusion treated with multimodal therapy including sirolimus targeting mTOR pathway.
